Pfizer Reports Additional Data from Epic-SR Study of Paxlovid

Continue reading


@pfizer.com | 1 year ago

Pfizer and Biontech Provide Update on Ongoing Studies of Covid-19 Vaccine

Continue reading


@pfizer.com | 2 years ago

Pfizer update: Three doses needed for omicron variant

Continue reading


@pfizer.com | 2 years ago

mRNA vaccine trial for Lyme disease

Continue reading


@pfizer.com | 2 years ago

Pfizer Confirms High Efficacy: Updated Topline Analysis

Continue reading


@pfizer.com | 3 years ago

Pfizer initiates phase 1 study of novel oral pill against SARS-CoV-2

Continue reading


@pfizer.com | 3 years ago

Pfizer submits Covid vaccine to FDA for approval, to distribute in December

Continue reading


@pfizer.com | 3 years ago

Pfizer/BioNTech Vaccine Achieved Success in First Analysis from Phase 3 Study

Continue reading


@pfizer.com | 3 years ago

Pfizer CEO's open letter on Covid-19 vaccine

Continue reading


@pfizer.com | 3 years ago